For example: Apple Inc, UTIL, Aluminum
Advaxis Inc
NASDAQ:ADXS
Market Close 01/15
0.61 USD -0.03 (-4.06%)
OPEN:
0.64
DAY RANGE:
0.60 - 0.65
PE:
-0.49
PB:
1.23
PS:
0.90
WTD % -
MTD % 74.94
QTD % 74.94
YTD % 74.94
* Updated at market close
Advaxis Inc (NASDAQ:ADXS) opened on Jan 15, 2021 at 0.64 USD and significantly decreased by -4.06%. The intraday price range was 0.60 - 0.65 USD and eventually ended the session at 0.61 USD. The stock trade volume was 8.16 M shares. The company's 52-week range is 0.26 - 1.35 USD.
Trading Statistics (Market Close Jan 15, 2021)
Market Cap 37.58 M
Outstanding Stock 3.52 M
Dividend 0.00
Dividend Yield 0.00
EPS -7.29
YTD Change 74.94%
52 Week's Range 0.26 - 1.35
Key Ratio & Margins (Market Close Jan 15, 2021)
Price/Earning -0.49
Price/Book Value 1.23
Price/Sales 0.90
ROA -
ROE -
Debt/Equity 0.15
Company Self Description
Advaxis, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of Listeria monocytogenes (Lm) technology based antigen delivery product in the United States. The company has collaboration and licensing agreements with OS Therapies LLC; Amgen Inc.; Especificos Stendhal SA de CV; Merck & Co., Inc.; MedImmune/AstraZeneca; Aratana Therapeutics Inc. It was founded in 2002 and is based in Princeton, New Jersey, United States.
Business Information
Advaxis Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Jan 15, 2021)
  ADXS ACHV CYCC LIFE
Daily Change (%) -4.06 7.26 -18.42 -1.95
WTD (%) - - - -
MTD (%) 74.94 20.37 -5.89 3.61
QTD (%) 74.94 20.37 -5.89 3.61
YTD (%) 74.94 20.37 -5.89 3.61
52-Week Change (%) -47.86 1,672.73 906.71 -41.14
Stock Performance (Market Close Jan 15, 2021)
  ADXS ACHV CYCC LIFE
Daily Change (%) -4.06 7.26 -18.42 -1.95
WTD (%) - - - -
MTD (%) 74.94 20.37 -5.89 3.61
QTD (%) 74.94 20.37 -5.89 3.61
YTD (%) 74.94 20.37 -5.89 3.61
52-Week Change (%) -47.86 1,672.73 906.71 -41.14
Key Fundamentals (Market Close Jan 15, 2021)
  ADXS ACHV CYCC LIFE
Market Cap 37.58 M 34.98 M 35.75 M 38.34 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -126.10% 0.00 0.00 -27,043.60%
P/E Ratio -0.49 -0.97 -0.90 -0.49
Price to Sales Ratio 0.90 0 0 177.08
Price to Book Ratio 1.23 0.52 0.50 0.44
Enterprise Value to EBITDA 0.17 0.29 1.33 -0.03
ROA - -100.20% -38.80% -48.10%
ROE - -127.00% -48.60% -76.80%
Debt/Equity 0.15 0.21 0.30 0.57
Asset Turnover Ratio 0.41 0 0 0.00
Current Ratio 2.21 4.75 4.45 4.69
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 6.06 M 12.03 M 3.99 M 0.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 6.06 M 12.03 M 3.99 M 0.00
Selling General & Administrative Expenses 19.47 M 39.97 M 31.71 M 24.24 M
Research & Development 56.97 M 70.51 M 48.77 M 24.46 M
Operating Income -70.38 M -98.45 M -76.49 M -48.70 M
Net Income -66.52 M -93.44 M -73.56 M -47.03 M
EPS -19.35 -34.65 -31.20 -25.20
Diluted EPS -19.35 -34.65 -31.20 -25.20
  Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Revenue 1.19 M 19.69 M 1.13 M 1.13 M
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 1.19 M 19.69 M 1.13 M 1.13 M
Selling General & Administrative Expenses 3.09 M 2.67 M 4.98 M 4.50 M
Research & Development 5.97 M 6.71 M 18.27 M 10.80 M
Operating Income -7.87 M 10.32 M -22.12 M -14.16 M
Net Income -9.38 M 12.82 M -18.60 M -14.02 M
EPS -1.59 2.70 -4.35 -4.05
Diluted EPS -1.59 2.70 -4.35 -4.05
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 50.47 M 81.24 M 159.88 M 115.01 M
Cash & Cash Equivalents 45.12 M 24.49 M 112.75 M 66.56 M
Total Assets 62.27 M 93.64 M 169.04 M 119.61 M
Total Current Liabilities 22.87 M 20.86 M 27.71 M 3.92 M
Total Liabilities 38.22 M 39.38 M 49.74 M 4.01 M
Shareholder's Equity 24.05 M 54.26 M 119.30 M 115.60 M
Outstanding Stock 3.52 M 2.74 M 2.66 M 2.22 M
  Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Total Current Assets 38.38 M 38.57 M 50.47 M 47.78 M
Cash & Cash Equivalents 33.71 M 32.71 M 45.12 M 40.41 M
Total Assets 49.77 M 50.30 M 62.27 M 61.06 M
Total Current Liabilities 5.42 M 11.63 M 22.87 M 12.11 M
Total Liabilities 6.60 M 12.80 M 38.22 M 27.73 M
Shareholder's Equity 43.17 M 37.50 M 24.05 M 33.33 M
Outstanding Stock 4.65 M 4.65 M 3.52 M 3.51 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -62.13 M -76.84 M -9.14 M -24.16 M
Capital Expenditures -1.43 M -3.45 M -3.22 M -972,859.00
Net Cash Flow from Investing Activities 43.17 M -12.46 M 1.56 M -47.45 M
Net Cash Flow from Financial Activities 39.20 M 447,000.00 53.78 M 120.57 M
Free Cash Flow -63.55 M -80.29 M -12.37 M -25.14 M
  Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Net Cash Flow from Operations -7.90 M -76.84 M -9.14 M -24.16 M
Capital Expenditures -1,000.00 -45,000.00 -44,000.00 -104,348.00
Net Cash Flow from Investing Activities -157,000.00 -552,000.00 -328,000.00 8.74 M
Net Cash Flow from Financial Activities 9.05 M 14,000.00 18.24 M -58,963.00
Free Cash Flow -7.90 M -11.92 M -13.25 M -18.23 M
Key Ratios (Market Close Jan 15, 2021)
Valuation Ratios 2021 2020 2019 2018
P/E Ratio -0.49 -0.58 -0.44 -0.91
Price to Sales Ratio 0.90 1.11 4.77 11.48
Price to Book Ratio 1.23 2.57 2.70 3.20
Enterprise Value to EBIT 0.00 -1.00 -4.00 -6.00
Enterprise Value to EBITDA 0.17 -1.28 -3.86 -5.62
Profitability Ratios 2021 2020 2019 2018
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - - -52.50%
ROE - - - -94.60%
Liquidity Ratios 2021 2020 2019 2018
Working Capital 27.59 M 60.38 M 132.17 M 111.10 M
Current Ratio 2.21 3.89 5.77 29.36
Efficiency & Capital Structure Ratios 2021 2020 2019 2018
Debt Equity Ratio 0.15 0.73 0.42 0.04
Asset Turnover Ratio - - - 0.38
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.